Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2017 1
2018 1
2019 1
2020 3
2024 5
2025 2
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

13 results

Results by year

Filters applied: . Clear all
Page 1
Postural Orthostatic Tachycardia Syndrome: Mechanisms and New Therapies.
Mar PL, Raj SR. Mar PL, et al. Annu Rev Med. 2020 Jan 27;71:235-248. doi: 10.1146/annurev-med-041818-011630. Epub 2019 Aug 14. Annu Rev Med. 2020. PMID: 31412221 Review.
The approach to the treatment of POTS centers on treating the underlying pathophysiologic mechanism. Stockings, abdominal binders, and vasoconstrictors are used to enhance venous return in partial neuropathic POTS. Exercise and volume expansion are the main t …
The approach to the treatment of POTS centers on treating the underlying pathophysiologic mechanism. Stockings, abdominal binders, an …
Pathophysiology and management of postural orthostatic tachycardia syndrome (POTS): A literature review.
Ghazal M, Akkawi AR, Fancher A, Oundo E, Tanzeem H, Sajjad L, Briasoulis A. Ghazal M, et al. Curr Probl Cardiol. 2025 Mar;50(3):102977. doi: 10.1016/j.cpcardiol.2024.102977. Epub 2024 Dec 18. Curr Probl Cardiol. 2025. PMID: 39706392 Review.
Recent studies have identified three primary POTS phenotypes-hyperadrenergic, neuropathic, and hypovolemic-each requiring tailored management strategies. ...Hypovolemic POTS, often triggered by dehydration and physical deconditioning, respond pr …
Recent studies have identified three primary POTS phenotypes-hyperadrenergic, neuropathic, and hypovolemic-each requiri …
Postural Orthostatic Tachycardia Syndrome: Prevalence, Pathophysiology, and Management.
Zadourian A, Doherty TA, Swiatkiewicz I, Taub PR. Zadourian A, et al. Drugs. 2018 Jul;78(10):983-994. doi: 10.1007/s40265-018-0931-5. Drugs. 2018. PMID: 29943373 Review.
In this review, a comprehensive framework is provided to aid in helping identify and treat patients with POTS. Given its heterogenous nature, it is crucial to understand each component of POTS in relation to one another instead of distinct parts. The framework highl …
In this review, a comprehensive framework is provided to aid in helping identify and treat patients with POTS. Given its heterogenous …
Update of Individualized Treatment Strategies for Postural Orthostatic Tachycardia Syndrome in Children.
Zhang Q, Xu B, Du J. Zhang Q, et al. Front Neurol. 2020 Jun 11;11:525. doi: 10.3389/fneur.2020.00525. eCollection 2020. Front Neurol. 2020. PMID: 32655482 Free PMC article. Review.
Postural orthostatic tachycardia syndrome (POTS) is a heterogeneous disease that predominantly affects children and adolescents. ...The three major clinical forms of POTS include hypovolemic POTS, neuropathic POTS, and hyperadrenergic …
Postural orthostatic tachycardia syndrome (POTS) is a heterogeneous disease that predominantly affects children and adolescents. ...T …
Metabolic targets in the Postural Orthostatic Tachycardia Syndrome: A short thematic review.
Glasgow AC, Kim JY. Glasgow AC, et al. Auton Neurosci. 2024 Dec;256:103232. doi: 10.1016/j.autneu.2024.103232. Epub 2024 Dec 2. Auton Neurosci. 2024. PMID: 39631266 Review.
POTS impacts approximately 1-3 million people in the U.S. alone, in which the majority of patients are premenopausal women. The etiology of POTS is multi-factorial with three primary clinical subtypes, including neuropathic, hyperadrenergic, and hypovolemi …
POTS impacts approximately 1-3 million people in the U.S. alone, in which the majority of patients are premenopausal women. The etiol …
Ivabradine in Postural Orthostatic Tachycardia Syndrome: A Review of the Literature.
Tahir F, Bin Arif T, Majid Z, Ahmed J, Khalid M. Tahir F, et al. Cureus. 2020 Apr 28;12(4):e7868. doi: 10.7759/cureus.7868. Cureus. 2020. PMID: 32489723 Free PMC article. Review.
The pathophysiology of POTS is not completely understood due to a variety of symptoms showing that the disease is multifactorial. ...Although beta-adrenoceptor blockers are commonly used to lower HR in patients with POTS, they are less ideal due to numerous adverse …
The pathophysiology of POTS is not completely understood due to a variety of symptoms showing that the disease is multifactorial. ... …
Postural Tachycardia Syndrome: Diagnosis and Management in Adolescents and Young Adults.
Heyer GL. Heyer GL. Pediatr Ann. 2017 Apr 1;46(4):e145-e154. doi: 10.3928/19382359-20170322-01. Pediatr Ann. 2017. PMID: 28414396 Review.
Although considerable overlap exists, three subtypes of POTS have been described: neuropathic, hyperadrenergic, and hypovolemic forms. The wide spectrum of symptoms and comorbidities can make treatment particularly challenging. ...Several medicines are also a …
Although considerable overlap exists, three subtypes of POTS have been described: neuropathic, hyperadrenergic, and hypovol …
Use of Ivabradine in the Treatment of Patients with Postural Orthostatic Tachycardia Syndrome (POTS): A Systematic Review.
Melo APG, Moretti MA, Chagas ACP. Melo APG, et al. Arq Bras Cardiol. 2025 Nov;122(11):e20250347. doi: 10.36660/abc.20250347. Arq Bras Cardiol. 2025. PMID: 41538594 Free PMC article. English, Portuguese.
There are three phenotypes of POTS - neuropathic, hypovolemic, and hyperadrenergic - and all result in tachycardia and altered cerebral perfusion. ...There are three phenotypes of POTS - neuropathic, hypovolemic, and hyperadrenergic - and …
There are three phenotypes of POTS - neuropathic, hypovolemic, and hyperadrenergic - and all result in tachycardia and …
Management of Postural Orthostatic Tachycardia Syndrome in Pediatric Patients: A Clinical Review.
Huynh P, Brown A, Campisi L, Mruk A, Nguyen T, Raschka M, Afolabi T. Huynh P, et al. J Pediatr Pharmacol Ther. 2024 Oct;29(5):456-467. doi: 10.5863/1551-6776-29.5.456. Epub 2024 Oct 14. J Pediatr Pharmacol Ther. 2024. PMID: 39411411 Free PMC article.
To date, there are no US Food and Drug Administration-approved agents for the treatment of POTS. However, select pharmacological therapies have shown positive outcomes by addressing symptom origins, such as providing heart rate control, peripheral autonomic modulation, and …
To date, there are no US Food and Drug Administration-approved agents for the treatment of POTS. However, select pharmacological ther …
Evaluation of the relationship between mast cell activation and postural orthostatic tachycardia syndrome in children and adolescents.
Bayrak YE, Kayabey O, Basar EZ, Simsek IE, Aydogan M, Babaoglu A. Bayrak YE, et al. North Clin Istanb. 2024 Aug 2;11(4):315-321. doi: 10.14744/nci.2023.64920. eCollection 2024. North Clin Istanb. 2024. PMID: 39165715 Free PMC article.
POTS is a multi-systemic disease. Many mechanisms have been defined in POTS etiology, such as autonomic denervation, hypovolemia, hyperadrenergic stimulation, low condition, and hypervigilance. ...CONCLUSION: In the literature, MCA was considered to be one of …
POTS is a multi-systemic disease. Many mechanisms have been defined in POTS etiology, such as autonomic denervation, hypovo …
13 results